Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Immunex patents

Patents where

Current Assignee

Name

Immunex

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7083948 Polypeptide purification reagents and methods for their use	Patent 7083948 was granted and assigned to Immunex on August, 2006 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7083948	August 1, 2006
‌ US Patent 7427669 ULBP antibodies	Patent 7427669 was granted and assigned to Immunex on September, 2008 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7427669	September 23, 2008
‌ US Patent 7186809 Methods and compositions relating to anti-interleukin-4 receptor antibodies	Patent 7186809 was granted and assigned to Immunex on March, 2007 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7186809	March 6, 2007
‌ US Patent 7465450 Methods and compositions relating to anti-interleukin-4 receptor antibodies	Patent 7465450 was granted and assigned to Immunex on December, 2008 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7465450	December 16, 2008
‌ US Patent 7129203 Site specific protein modification	Patent 7129203 was granted and assigned to Immunex on October, 2006 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7129203	October 31, 2006
‌ US Patent 7872113 Nucleic acids encoding antibodies that bind interleukin-4 receptor	Patent 7872113 was granted and assigned to Immunex on January, 2011 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7872113	January 18, 2011
‌ US Patent 7638606 Antibodies that bind interleukin-4 receptor	Patent 7638606 was granted and assigned to Immunex on December, 2009 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7638606	December 29, 2009
‌ US Patent 7273609 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L	Patent 7273609 was granted and assigned to Immunex on September, 2007 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7273609	September 25, 2007
‌ US Patent 7138500 Antibodies to human 4-1BB	Patent 7138500 was granted and assigned to Immunex on November, 2006 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7138500	November 21, 2006
‌ US Patent 7645609 Method for controlling sialylation of proteins produced by mammalian cells	Patent 7645609 was granted and assigned to Immunex on January, 2010 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7645609	January 12, 2010
‌ US Patent 7659375 Human IL-1 epsilon DNA and polypeptides	Patent 7659375 was granted and assigned to Immunex on February, 2010 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7659375	February 9, 2010
‌ US Patent 7122641 Methods for purifying protein	Patent 7122641 was granted and assigned to Immunex on October, 2006 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7122641	October 17, 2006
‌ US Patent 7211259 4-1BB polypeptides and DNA encoding 4-1BB polypeptides	Patent 7211259 was granted and assigned to Immunex on May, 2007 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7211259	May 1, 2007
‌ US Patent 7834157 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)	Patent 7834157 was granted and assigned to Immunex on November, 2010 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7834157	November 16, 2010
‌ US Patent 7101982 Control of ph transitions during chromatography	Patent 7101982 was granted and assigned to Immunex on September, 2006 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7101982	September 5, 2006
‌ US Patent 7572594 Screening assays for agonists or antagonists or receptor activator of NF-κB	Patent 7572594 was granted and assigned to Immunex on August, 2009 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7572594	August 11, 2009
‌ US Patent 7232660 CD30 ligand	Patent 7232660 was granted and assigned to Immunex on June, 2007 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7232660	June 19, 2007
‌ US Patent 7261894 Methods of treating inflammatory and/or autoimmune disease	Patent 7261894 was granted and assigned to Immunex on August, 2007 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7261894	August 28, 2007
‌ US Patent 6838290 Methods for screening compounds that affect IL-1 epsilon activity	Patent 6838290 was granted and assigned to Immunex on January, 2005 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	6838290	January 4, 2005
‌ US Patent 7175849 Nectin polypeptides	Patent 7175849 was granted and assigned to Immunex on February, 2007 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7175849	February 13, 2007
‌ US Patent 7199224 Antibodies that bind TNF-α converting enzyme	Patent 7199224 was granted and assigned to Immunex on April, 2007 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7199224	April 3, 2007
‌ US Patent 7294331 Methods of using flt3-ligand in hematopoietic cell transplantation	Patent 7294331 was granted and assigned to Immunex on November, 2007 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7294331	November 13, 2007
‌ US Patent 7544784 Increased recovery of active proteins	Patent 7544784 was granted and assigned to Immunex on June, 2009 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7544784	June 9, 2009
‌ US Patent 7244822 BTL-II proteins	Patent 7244822 was granted and assigned to Immunex on July, 2007 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7244822	July 17, 2007
‌ US Patent 7157557 Increased recovery of active proteins	Patent 7157557 was granted and assigned to Immunex on January, 2007 by the United States Patent and Trademark Office.	Immunex	United States Patent and Trademark Office	7157557	January 2, 2007

...

Results per page:

158 results

0 selected

158 results

0 selected